EP3943070
LANGVERKANDI SAMSETNINGAR AF BEDAKVÍLÍNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.7.2018EP published:
22.11.2023EP application number:
21178526.6
EP translation filed:
22.1.2024Grant published:
15.2.2024EPO information:
European Patent Register
Max expiry date:
12.7.2038Expiry date:
12.7.2026Next due date:
31.7.2026
Title in English:
LONG-ACTING FORMULATIONS OF BEDAQUILINELanguage of the patent:
English
Timeline
Today
13.7.2018EP application
22.11.2023EP Publication
22.1.2024Translation submitted
15.2.2024Registration published
12.7.2026Expires
Owner
Name:
Janssen Pharmaceutica NVAddress:
Turnhoutseweg 30, 2340 Beerse, BE
Inventor
Name:
Andries, Koenraad, Jozef, Lodewijk, MarcelAddress:
2340 Beerse, BE
Name:
BASSTANIE, Esther, Dina, GuidoAddress:
2340 Beerse, BE
Name:
BERNINI, MaristellaAddress:
2340 Beerse, BE
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
17181354Date:
14.7.2017Country:
EP
Number:
18167463Date:
16.4.2018Country:
EP
Classification
Categories:
A61K 9/10, A61K 47/26, A61K 31/47, A61P 31/06, A61P 31/08
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 6.6.2024
Expires: 12.7.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.7.2025
Expires: 12.7.2026
Payer: Árnason Faktor ehf.